drugset / Trial / NCT00005028
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
Phase 2
Completed
46 enrolled
University of Maryland, Baltimore
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of combining paclitaxel and bryostatin 1 in treating patients who have metastatic prostate cancer that has not responded to hormone therapy. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
Timeline
- Start
- 2000-05
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | — | Intravenous |
| Subject | bryostatin 1 | Small molecule | — | Intravenous |